STOCK TITAN
  1. Home
  2. Sec-filings
  3. SLGL
  4. [EFFECT] Sol-Gel Technologies Ltd. SEC Filing

[EFFECT] Sol-Gel Technologies Ltd. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 23, 2026
Accession Number: 0001178913-26-001563
Submission Type: POS AM
CIK: 0001684693
Company Name: Sol-Gel Technologies Ltd.
File Number: 333-270478

Source: View Original Filing on SEC EDGAR

Sol Gel Tech

NASDAQ:SLGL

View SLGL Stock Overview →

SLGL Rankings

#4399 Ranked by Market Cap
N/A Ranked by Dividends

SLGL Latest News

Mar 23, 2026
Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering
Mar 19, 2026
Sol-Gel Files Annual Report on Form 20-F for the Year Ended December 31, 2025
Dec 17, 2025
Sol-Gel Provides Update Following Unblinding of Phase 1b Study of SGT-210 in Darier Disease
Nov 20, 2025
Sol-Gel Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
Sep 4, 2025
Sol-Gel Announces Health Canada Approval of EPSOLAY®

SLGL Latest SEC Filings

Mar 24, 2026
[6-K] Sol-Gel Technologies Ltd. Current Report (Foreign Issuer)
Mar 24, 2026
[424B5] Sol-Gel Technologies Ltd. Prospectus Supplement (Debt Securities)
Mar 24, 2026
[Form 4] Sol-Gel Technologies Ltd. Insider Trading Activity
Mar 23, 2026
[SCHEDULE 13G/A] Sol-Gel Technologies Ltd. Amended Passive Investment Disclosure
Mar 19, 2026
[POS AM] Sol-Gel Technologies Ltd. SEC Filing

SLGL Stock Data

218.47M
835.67k
Biotechnology
Healthcare
Link
Israel
Ness Ziona